Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapeutic strategies for cervical squamous carcinoma.
van Driel WJ, Kenter GG, Fleuren GJ, Melief CJ, Trimbos BJ. van Driel WJ, et al. Among authors: melief cj. Hematol Oncol Clin North Am. 1999 Feb;13(1):259-73. doi: 10.1016/s0889-8588(05)70164-7. Hematol Oncol Clin North Am. 1999. PMID: 10080080 Review.
The current status of therapeutic HPV vaccine.
van Driel WJ, Ressing ME, Brandt RM, Toes RE, Fleuren GJ, Trimbos JB, Kast WM, Melief CJ. van Driel WJ, et al. Among authors: melief cj. Ann Med. 1996 Dec;28(6):471-7. doi: 10.3109/07853899608999110. Ann Med. 1996. PMID: 9017105 Review.
Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.
Vierboom MP, Nijman HW, Offringa R, van der Voort EI, van Hall T, van den Broek L, Fleuren GJ, Kenemans P, Kast WM, Melief CJ. Vierboom MP, et al. Among authors: melief cj. J Exp Med. 1997 Aug 29;186(5):695-704. doi: 10.1084/jem.186.5.695. J Exp Med. 1997. PMID: 9271585 Free PMC article.
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.
Ressing ME, de Jong JH, Brandt RM, Drijfhout JW, Benckhuijsen WE, Schreuder GM, Offringa R, Kast WM, Melief CJ. Ressing ME, et al. Among authors: melief cj. Eur J Immunol. 1999 Apr;29(4):1292-303. doi: 10.1002/(SICI)1521-4141(199904)29:04<1292::AID-IMMU1292>3.0.CO;2-6. Eur J Immunol. 1999. PMID: 10229097 Free article.
HLA and susceptibility to cervical neoplasia.
Krul EJ, Schipper RF, Schreuder GM, Fleuren GJ, Kenter GG, Melief CJ. Krul EJ, et al. Among authors: melief cj. Hum Immunol. 1999 Apr;60(4):337-42. doi: 10.1016/s0198-8859(98)00127-x. Hum Immunol. 1999. PMID: 10363725 Clinical Trial.
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial.
van Driel WJ, Ressing ME, Kenter GG, Brandt RM, Krul EJ, van Rossum AB, Schuuring E, Offringa R, Bauknecht T, Tamm-Hermelink A, van Dam PA, Fleuren GJ, Kast WM, Melief CJ, Trimbos JB. van Driel WJ, et al. Among authors: melief cj. Eur J Cancer. 1999 Jun;35(6):946-52. doi: 10.1016/s0959-8049(99)00048-9. Eur J Cancer. 1999. PMID: 10533477 Clinical Trial.
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
Ressing ME, van Driel WJ, Brandt RM, Kenter GG, de Jong JH, Bauknecht T, Fleuren GJ, Hoogerhout P, Offringa R, Sette A, Celis E, Grey H, Trimbos BJ, Kast WM, Melief CJ. Ressing ME, et al. Among authors: melief cj. J Immunother. 2000 Mar-Apr;23(2):255-66. doi: 10.1097/00002371-200003000-00010. J Immunother. 2000. PMID: 10746552
Strategies for immunotherapy of cancer.
Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R. Melief CJ, et al. Adv Immunol. 2000;75:235-82. doi: 10.1016/s0065-2776(00)75006-1. Adv Immunol. 2000. PMID: 10879286 Review. No abstract available.
543 results